Literature DB >> 1512051

The role of the mucosal immune system in inflammatory bowel disease.

S Schreiber1, A Raedler, W F Stenson, R P MacDermott.   

Abstract

Continued delineation of the major factors that lead to intestinal inflammation will provide critical insights into many of the pathophysiologic events leading to tissue destruction in IBD. The exploration of exciting and important new areas, such as the role of adhesion molecules, proinflammatory cytokines, and the activation of lymphocytes and phagocytes, will contribute significantly to a better understanding of the mechanisms that sustain the intestinal inflammatory process. Determining the mechanisms of amplification and perpetuation of intestinal inflammation as well as learning more about the natural suppression of intestinal inflammation by the normal cellular and cytokine networks of the mucosal immune system will open exciting new therapeutic approaches. It is encouraging to see realistic and testable working models emerge from the combined efforts of many committed investigators who have been engaged in studying the role of the mucosal immune system in the pathophysiology of IBD. A great deal more remains to be learned in this rapidly advancing area, and we can look forward with confidence to continued advances in the study of IBD.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1512051

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  29 in total

1.  Cellular localization of complement C3 and C4 transcripts in intestinal specimens from patients with Crohn's disease.

Authors:  J Laufer; R Oren; I Goldberg; A Horwitz; J Kopolovic; Y Chowers; J H Passwell
Journal:  Clin Exp Immunol       Date:  2000-04       Impact factor: 4.330

2.  Impaired mitogenic response of peripheral blood T cells in ulcerative colitis is not due to apoptosis.

Authors:  M A Pérez-Machado; L M Espinosa; E J de la Madrigal; L Abreu; G M Lorente; M Alvarez-Mon
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

3.  Induction of apoptosis of lymphocytes in rat mucosal immune system.

Authors:  Xue-Qing Chen; Wan-Dai Zhang; Yu-Gang Song; Dian-Yuan Zhou
Journal:  World J Gastroenterol       Date:  1998-02       Impact factor: 5.742

4.  Study of the mechanisms of acupuncture and moxibustion treatment for ulcerative colitis rats in view of the gene expression of cytokines.

Authors:  Huan-Gan Wu; Li-Bin Zhou; Ying-Ying Pan; Cheng Huang; Han-Ping Chen; Zheng Shi; Xue-Gui Hua
Journal:  World J Gastroenterol       Date:  1999-12       Impact factor: 5.742

5.  Prophylactic and therapeutic effects of oral budesonide for acute radiation-induced enteritis and colitis in rats.

Authors:  Mehmet Odabasi; Suleyman Gokdemir; Tolga Muftuoglu; Ali Aktekin; Abdullah Saglam; Fugen Aker
Journal:  Int J Clin Exp Med       Date:  2014-04-15

6.  Molecular evidence for two forms of Crohn disease.

Authors:  E C Gilberts; A J Greenstein; P Katsel; N Harpaz; R J Greenstein
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

7.  A stable nitroxide radical effectively decreases mucosal damage in experimental colitis.

Authors:  F Karmeli; R Eliakim; E Okon; A Samuni; D Rachmilewitz
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

Review 8.  Adenosine: an immune modulator of inflammatory bowel diseases.

Authors:  Jeff Huaqing Ye; Vazhaikkurichi M Rajendran
Journal:  World J Gastroenterol       Date:  2009-09-28       Impact factor: 5.742

9.  Grifola frondosa water extract alleviates intestinal inflammation by suppressing TNF-alpha production and its signaling.

Authors:  Jong Suk Lee; Su Young Park; Dinesh Thapa; Mi Kyoung Choi; Ill Min Chung; Young Joon Park; Chul Soon Yong; Han Gon Choi; Jung Ae Kim
Journal:  Exp Mol Med       Date:  2010-02-28       Impact factor: 8.718

10.  An increased risk of Crohn's disease in individuals who inherit the HLA class II DRB3*0301 allele.

Authors:  D G Forcione; B Sands; K J Isselbacher; A Rustgi; D K Podolsky; S Pillai
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.